Company Performance Metrics
AbMax offers a one-stop antibody and kit development technology platform and an antibody humanization technology platform. It has become one of the five emergency projects of the Beijing Municipal Science and Technology Commission (2 million ) and one of the Gates Foundation’s seven Chinese projects on the new crown epidemic (700,000). The company
has also undertaken a number of national 863 plan projects and Beijing science and technology plan projects, maintained in-depth and extensive cooperation with well-known scientific research institutions and enterprises at home and abroad, established a standardized quality management system, and passed the ISO9001:2008 system certification.
The company was founded in 2006 and is based in Beijing, China.
